| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |